The document “Notification of Issue, Conversion of Payment up of Unquoted Equity +Securities” was lodged with ASX on 9 February, 2021.
Please click to review the full announcement at ASX.
Imagion Biosystems Delivers Major Milestone — IND Application Lodged with U.S. FDA for Phase 2 Trial of MagSense® HER2 Imaging Agent
January 31, 2026
Imagion Biosystems Hits Major Milestone, Submits IND Application to U.S. FDA for Phase 2 Trial of MagSense® HER2 Imaging Agent Key Highlights: Imagion Biosystems has